Literature DB >> 17586494

Regulation of cell death and survival pathways in experimental glaucoma.

Hani Levkovitch-Verbin1, Noga Harizman, Rima Dardik, Yael Nisgav, Shelly Vander, Shlomo Melamed.   

Abstract

This study investigates cell death and survival pathways in experimental glaucoma using the translimbal photocoagulation laser model. Glaucoma was induced unilaterally in 79 Wistar rats and all eyes developed elevated intraocular pressure. The involvement of caspase-3, p-AKT and members of the MAP kinase pathway was evaluated by immunohistochemistry and Western blotting. We found that protein levels of caspase-3 were elevated from day 15 to day 30 (p<0.05). All investigated members of the MAP kinase pathway were significantly activated. P-SAPK/JNK activation began on day 2, reaching a 6-fold elevation by day 30 (p<0.05). The p-P38 level was elevated on days 2 and 8 (p<0.05), followed by a decrease to baseline on day 15. The level of p-ATF-2, the substrate of P38, was significantly elevated at all time points tested, up to day 30 (p<0.05). P-ERK was detected early (p<0.05) on day 1, returning to normal on day 15. The pro-survival protein p-Akt, a member of the PI3-kinase survival pathway, was also detected early on day 1 (p<0.05) returning to baseline on day 8 and remaining unchanged up to 64days. We conclude that retinal ganglion cell death in glaucoma involves activation, at different time points, of multiple pro-apoptotic pathways (the MAP kinase pathway and the caspase family) and pro-survival (PI-3 Kinase/ Akt and p-ERK).

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17586494     DOI: 10.1016/j.exer.2007.04.011

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  24 in total

1.  Preservation of retina ganglion cell function by morphine in a chronic ocular-hypertensive rat model.

Authors:  Shahid Husain; Yasir Abdul; Craig E Crosson
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-06-28       Impact factor: 4.799

2.  Lack of neuroprotection against experimental glaucoma in c-Jun N-terminal kinase 3 knockout mice.

Authors:  Harry A Quigley; Frances E Cone; Scott E Gelman; Zhiyong Yang; Janice L Son; Ericka N Oglesby; Mary E Pease; Donald J Zack
Journal:  Exp Eye Res       Date:  2011-01-25       Impact factor: 3.467

3.  Retinal cell responses to elevated intraocular pressure: a gene array comparison between the whole retina and retinal ganglion cell layer.

Authors:  Ying Guo; William O Cepurna; Jennifer A Dyck; Tom A Doser; Elaine C Johnson; John C Morrison
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-01-13       Impact factor: 4.799

Review 4.  Differential gene expression in glaucoma.

Authors:  Tatjana C Jakobs
Journal:  Cold Spring Harb Perspect Med       Date:  2014-07-01       Impact factor: 6.915

5.  Activation of TLR3 promotes the degeneration of retinal ganglion cells by upregulating the protein levels of JNK3.

Authors:  Shravan K Chintala; Nahrain Putris; Mason Geno
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-01-06       Impact factor: 4.799

Review 6.  Targets of Neuroprotection in Glaucoma.

Authors:  Shaoqing He; Dorota L Stankowska; Dorette Z Ellis; Raghu R Krishnamoorthy; Thomas Yorio
Journal:  J Ocul Pharmacol Ther       Date:  2017-08-18       Impact factor: 2.671

Review 7.  Mechanisms of retinal ganglion cell injury and defense in glaucoma.

Authors:  Juan Qu; Danyi Wang; Cynthia L Grosskreutz
Journal:  Exp Eye Res       Date:  2010-04-13       Impact factor: 3.467

Review 8.  Neurotrophin roles in retinal ganglion cell survival: lessons from rat glaucoma models.

Authors:  Elaine C Johnson; Ying Guo; William O Cepurna; John C Morrison
Journal:  Exp Eye Res       Date:  2009-02-14       Impact factor: 3.467

9.  RGS2-deficient mice exhibit decreased intraocular pressure and increased retinal ganglion cell survival.

Authors:  Miyuki Inoue-Mochita; Toshihiro Inoue; David L Epstein; Kendall J Blumer; Ponugoti V Rao
Journal:  Mol Vis       Date:  2009-03-06       Impact factor: 2.367

Review 10.  Oxidative stress and potential applications of free radical scavengers in glaucoma.

Authors:  Mutay Aslan; Serdar Dogan; Ertan Kucuksayan
Journal:  Redox Rep       Date:  2013-03-06       Impact factor: 4.412

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.